Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study
Nintedanib and pirfenidone exhibited similar long-term efficacy. Dose adjustment was more frequent with nintedanib, however it did not have impact on clinical outcomes.
Authors
- Giacomo Sgalla (ORCID: https://orcid.org/0000-0003-3130-9388)
- Bruno Iovene (ORCID: https://orcid.org/0000-0002-6381-1850)
- Francesca Lalla (ORCID: https://orcid.org/0000-0001-8576-3450)
- Francesco Varone (ORCID: https://orcid.org/0000-0003-2443-8069)
- Luca Richeldi
- Antonio Latella
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1186/s12890-025-03916-2
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Chiesi Farmaceutici